Cargando…
Case Report: Clinical Outcome and Image Response of Two Patients With Secondary High-Grade Glioma Treated With Chemoradiation, PCV, and Cannabidiol
We describe two patients with a confirmed diagnosis of high-grade gliomas (grades III/IV), both presenting with O6-methylguanine-DNA methyltransferase (MGMT) methylated and isocitrate dehydrogenase (IDH-1) mutated who, after subtotal resection, were submitted to chemoradiation and followed by PCV, a...
Autores principales: | Dall'Stella, Paula B., Docema, Marcos F. L., Maldaun, Marcos V. C., Feher, Olavo, Lancellotti, Carmen L. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6345719/ https://www.ncbi.nlm.nih.gov/pubmed/30713832 http://dx.doi.org/10.3389/fonc.2018.00643 |
Ejemplares similares
-
The Impact of Timing of Concurrent Chemoradiation in Patients With High-Grade Glioma in the Era of the Stupp Protocol
por: Warren, Kwanza T., et al.
Publicado: (2019) -
Initial PCV Chemotherapy Followed by Radiotherapy Is Associated With a Prolonged Response But Late Neurotoxicity in 20 Diffuse Low-Grade Glioma Patients
por: Blonski, Marie, et al.
Publicado: (2022) -
Editorial: The Role of Modern Neuro-oncology in the Treatment of Primary CNS Tumors, and Brain and Spinal Metastases
por: Maldaun, Marcos, et al.
Publicado: (2020) -
Preclinical modeling of lower-grade gliomas
por: Tang, Lilly W., et al.
Publicado: (2023) -
Radiation and chemotherapy for high‐risk lower grade gliomas: Choosing between temozolomide and PCV
por: McDuff, Susan G. R., et al.
Publicado: (2019)